Symbol
BioCryst Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$10.79
Current price of the stock
$4M
Trading volume of the stock
$2.2B
Market capitalization of the company
Mid Cap
Category of market capitalization
28.39%
Long-term growth mean estimate
4.67
Mean analyst rating
52.92%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-1.78
Total debt to total equity ratio
2.78
Current ratio
97.26%
Gross profit margin
6.57%
Operating profit margin
6.57%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-11.48%
Pretax profit margin
-11.99%
Net profit margin
2.99%
Measures profitability relative to shareholders' equity
2.99%
ROE excluding intangible assets
-2.86%
Measures profitability relative to total assets
-4.26%
Measures profitability relative to invested capital
0.24
Asset turnover ratio
0.42
Inventory turnover ratio
1.62
Receivables turnover ratio
55.69
Average number of days it takes to collect receivables
-17.69
Measures valuation relative to earnings
44.96
P/E based on future earnings estimates
5.41
Measures valuation relative to sales
-4.77
Measures valuation relative to book value
-8.64
Measures valuation relative to operating cash flow
-8.53
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
